The Aporia
Curia Invests $28 Million in Sterile API Manufacturing. (2026, October 5). Toronto Star. https://www.thestar.com/globenewswire/curia-invests-28-million-in-sterile-api-manufacturing/article_9e0b3851-d68d-5a0b-ad0a-3e5370357fae.html
“Curia Invests $28 Million in Sterile API Manufacturing.” Toronto Star, 5 Oct. 2026, https://www.thestar.com/globenewswire/curia-invests-28-million-in-sterile-api-manufacturing/article_9e0b3851-d68d-5a0b-ad0a-3e5370357fae.html.
“Curia Invests $28 Million in Sterile API Manufacturing.” Toronto Star, October 5, 2026. https://www.thestar.com/globenewswire/curia-invests-28-million-in-sterile-api-manufacturing/article_9e0b3851-d68d-5a0b-ad0a-3e5370357fae.html.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
Curia Global, a leading contract development and manufacturing organization (CDMO), has announced an investment of $28 million in expanding its sterile API manufacturing capabilities for both steroid and non-steroid products in Valladolid, Spain. The expansion aims to support the production scale from grams to metric tons, enhance sterility assurance, reduce contamination risks, and offer customizable aseptic packaging configurations. This initiative is expected to be completed by the fourth quarter of 2028. The project will incorporate advanced technologies such as closed systems with barrier isolators for primary containment and minimized operator interaction through integrated service panels, thereby enhancing support for injectable suspensions and other complex sterile formulations.